{"product_id":"scripps-36th-annual-new-treatments","title":"Scripps 36th Annual New Treatments In Chronic Liver Disease 2022","description":"\u003cdiv class=\"titleBar\"\u003e\n\u003cdiv id=\"MainContent_MainContent_ucLearningActivityCatalog_Details___learningActivityCatalog_SideBySideDetails_pnlLearningActivitySubtitle\"\u003e\n\u003ch4\u003eScripps 36th Annual New Treatments In Chronic Liver Disease 2022 (Videos)\u003c\/h4\u003e\n\u003cbr\u003eThis conference will review the latest medications and therapies in liver treatment and transplantation. The results of trials and real world data using oral drugs to treat chronic viral hepatitis B and C, non-alcoholic fatty liver diseases, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma and complications of end-stage liver disease including thrombocytopenia will be reviewed in detail. New Treatments in Chronic Liver Disease is a comprehensive yet concise program for updating physicians on these and other commonly encountered problems in the treatment of liver diseases.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eEducational Objectives\u003c\/strong\u003e\u003cbr\u003eAfter attending this live activity, participants should be able to:\u003cbr\u003e• Assess AASLD guidelines on viral hepatitis, autoimmune hepatitis and reproductive health, and chronic liver disease.\u003cbr\u003e• Review vascular disorders and coagulation management principles for patients with chronic liver disease.\u003cbr\u003e• Summarize guidelines on NAFLD (AGA), DILI and hemochromatosis (ACG) and non-invasive markers of fibrosis (EASL).\u003cbr\u003e• Evaluate drugs in development for PBC and PSC.\u003cbr\u003e• Employ strategies for treating and managing ascites and hepatorenal syndrome.\u003cbr\u003e• Describe advances in HCC therapy and management of acute-on-chronic liver disease.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\u003cbr\u003e• Hepatologists\u003cbr\u003e• Gastroenterologists\u003cbr\u003e• Infectious Disease Specialist\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTopics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eACG Guidelines for DILI and Hemochromatosis – Kris Kowdley, MD\u003cbr\u003eAcute-on-Chronic Liver Disease – Timothy Morgan, MD\u003cbr\u003eAdvanced Endoscopy in Liver Disease Patients – Matthew Skinner, MD\u003cbr\u003eAdvances in HCC – Catherine Frenette, MD\u003cbr\u003eAGA Guidelines for NAFLD – Mazen Noureddin, MD\u003cbr\u003eAutoimmune Hepatitis – John Vierling, MD\u003cbr\u003eDebate- Use of Semaglutide for Obese Patients with NAFLD – Paul J. Pockros, MD, Michael Charlton, MD\u003cbr\u003eEASL Guidelines for Non-Invasive Testing – Michael Charlton, MD\u003cbr\u003ePanel Discussion1\u003cbr\u003ePanel Discussion2\u003cbr\u003ePanel Discussion3\u003cbr\u003eReproductive Health and Chronic Liver Disease – Norah Terrault, MD\u003cbr\u003eUpdate on Management of Ascites and HRS – Florence Wong, MD\u003cbr\u003eVascular Disorders and Anticoagulation – Patrick Northup, MD\u003cbr\u003eViral Hepatitis B and C – Julio Gutierrez, MD\u003cbr\u003eWhen to Refer for Liver Transplantation – Adam Deising, MD\u003cbr\u003eWILLIAM S. HAUBRICH LECTURE- What’s New in PBC and PSC- – Kris Kowdley, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954401972322,"sku":"MED-AMB02766","price":20.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Scripps-36th-Annual-New-Treatments-In-Chronic-Liver-Disease-2022-Videos.jpg?v=1779375517","url":"https:\/\/meducourse.com\/products\/scripps-36th-annual-new-treatments","provider":"Meducourse","version":"1.0","type":"link"}